Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ XXXQA Y-,C
AH:0h X6+
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© *0_Q0SeE,o
#W4
" ^#2
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© F><ficT
xX.{(er
1.Co-stimulators (or co-stimulating molecules) 7s Gf_`Z
WfYG#!}x
2.NK-kB vb9C&
#
7}pg7EF3z
3.Immunoglobulin superfamily HKVtO%&
c IPOI'3d
4.antigen-presenting cell (APC) ;R$2+9
X, }(MW
5.death domain aYc^ 9*7
K{ntl-D&y
6.CCR and CXCR eYevj[c;
,E"n 7*6mr
7.Lectin (or mitogen) BKYyc6iE
}hcY5E-n
8.Clusters of differentiation, CD) $weC '-n@
o/&
IT(v
9.B7 family m ^w{:\p
ZKM@U?PK
10.Cytotoxic T lymphocyte, CTL) (O&HCT|
[GcW*v
11.IL-15 and IL-15 receptor (IL-15R) by\Sq}
)"7z'ar
12.MHC restriction l hST%3Ld
+=sw&DH
13.Affinity-chromatography 9Q'[>P=1
Q 9E.AN
14.Cyctosprin A, CsA +k[w)7Q
Eu%E2A|`I
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) hE<Sm*HU
9SJSUv:@
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© U*,\UF
G,<l}(tEG
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 S)/548=`
Ul}<@d9: B
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ f.$*9Fkw
%jHe_8=o
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ H!>>|6OPF
mI]gDL1
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© [B +:)i
y
~su1wUp
ÃâÒßѧרҵ£º *z.rOY=
8
X5)(,036
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ Et0)6^-v
cBv"d ~
Ïû»¯ÄÚ¿Æ£º .2s^8 g O
tGzp=PyA
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ !
h92dH
7[!dm_
ѪҺ²¡Ñ§×¨Òµ£º 29m$
S7[
3s67)n
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿